Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 - ROCKWELL MEDICAL, INC. | rmti-20170630ex3129f1438.htm |
| EX-31.1 - EX-31.1 - ROCKWELL MEDICAL, INC. | rmti-20170630ex311da4784.htm |
| EX-10.69 - EX-10.69 - ROCKWELL MEDICAL, INC. | rmti-20170630ex1069b5213.htm |
| EX-10.68 - EX-10.68 - ROCKWELL MEDICAL, INC. | rmti-20170630ex1068b1408.htm |
| 10-Q - 10-Q - ROCKWELL MEDICAL, INC. | rmti-20170630x10q.htm |
EXHIBIT 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
AND CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Rockwell Medical, Inc. (the “Company”) on Form 10-Q for the quarter ending June 30, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Periodic Report”), I, Robert L. Chioini, Chief Executive Officer of the Company and I, Thomas E. Klema, Chief Financial Officer of the Company, each certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:
1.the Periodic Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.the information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Dated: August 9, 2017 |
/s/ Robert L. Chioini |
|
|
Robert L. Chioini |
|
|
President and Chief Executive Officer |
|
|
|
|
Dated: August 9, 2017 |
/s/ Thomas E. Klema |
|
|
Thomas E. Klema |
|
|
Vice President and Chief Financial Officer |